Patents by Inventor Kenneth James Shaw

Kenneth James Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C20ORF23 as modifier of the IGFR pathway and methods of use
    Patent number: 7943302
    Abstract: Human C20ORF23 genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of C20ORF23 are provided.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: May 17, 2011
    Assignee: Exelixis, Inc.
    Inventors: Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Lynn Margaret Bjerke, Timothy S. Heuer
  • P4HAS as modifiers of the IGFR pathway and methods of use
    Patent number: 7888048
    Abstract: Human P4HA genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of P4HA are provided.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: February 15, 2011
    Assignee: Exelixis, Inc.
    Inventors: Lori S. Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Timothy S. Heuer, Lynn Margaret Bjerke
  • PDEs as modifiers of the IGFR pathways and methods of use
    Patent number: 7888047
    Abstract: Human PDE genes are identified as modulators of the IGFR pathway and thus are therapeutic targets for disorders associated with defective IGFR function Methods for identifying modulators of IGFR comprising screening for agents that modulate the activity of PDE are provided.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: February 15, 2011
    Assignee: Exelixis, Inc.
    Inventors: Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Lynn Margaret Bjerke, Timothy S. Heuer
  • MAN2As as modifiers of the IGFR pathway and methods of use
    Patent number: 7785805
    Abstract: Human MAN2A genes are identified as modulators of the IGFR pathway and thus are therapeutic targets for disorders associated with defective IGFR function Methods for identifying modulators of IGFR comprising screening for agents that modulate the activity of MAN2A are provided.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: August 31, 2010
    Assignee: Exelixis, Inc.
    Inventors: Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, HaiGuang Zhang, Timothy S. Heuer
  • C20ORF23 as modifier of the IGFR pathway and methods of use
    Publication number: 20090202563
    Abstract: Human C20ORF23 genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of C20ORF23 are provided.
    Type: Application
    Filed: March 10, 2005
    Publication date: August 13, 2009
    Applicant: EXELIXIS, INC.
    Inventors: Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Lynn Margaret Bjerke, Timothy S. Heuer
  • Pfks as modifiers of the igfr pathway and methods of use
    Publication number: 20090142272
    Abstract: Human PFK genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of PFK are provided.
    Type: Application
    Filed: June 20, 2005
    Publication date: June 4, 2009
    Applicant: Exelixis, Inc.
    Inventors: Lori S. Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Lynn Margaret Bjerke, Timothy S. Heuer
  • GALNTS AS MODIFIERS OF THE IGFR PATHWAY AND METHODS OF USE
    Publication number: 20090028844
    Abstract: Human MIGFR genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of MIGFR are provided.
    Type: Application
    Filed: June 20, 2005
    Publication date: January 29, 2009
    Applicant: EXELIXIS, INC.
    Inventors: Lori S. Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Timothy S. Heuer, Lynn Margaret Bjerke
  • P4HAS AS MODIFIERS OF THE IGFR PATHWAY AND METHODS OF USE
    Publication number: 20090025096
    Abstract: Human P4HA genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of P4HA are provided.
    Type: Application
    Filed: June 20, 2005
    Publication date: January 22, 2009
    Applicant: EXELIXIS, INC.
    Inventors: Lori S. Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Timothy S. Heuer, Lynn Margaret Bjerke
  • PDES AS MODIFIERS OF THE IGFR PATHWAYS AND METHODS OF USE
    Publication number: 20090013416
    Abstract: Human PDE genes are identified as modulators of the IGFR pathway and thus are therapeutic targets for disorders associated with defective IGFR function Methods for identifying modulators of IGFR comprising screening for agents that modulate the activity of PDE are provided
    Type: Application
    Filed: March 10, 2005
    Publication date: January 8, 2009
    Applicant: EXELIXIS, INC.
    Inventors: Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, Lynn Margaret Bjerke, Timothy S. Heuer